# Phil Rivers

Provider of solutions for AI pharmaceutical research and development.

Zheyuan Technology is an AI pharmaceutical research and development solutions provider

Canonical: https://uniquebase.ai/companies/zheyuankeji
Stable identifier: UB-C3525
Snapshot captured: 2026-10-20T18:05:01.520Z
English updated: 2026-10-20T18:23:29.560Z

## Funding

Listed 3 records.
Latest: RMB 200M (Series A+), 2026-03-12.

- 2026-03-12 · RMB 200M (≈ $28.6M) · Series A+ · 中科创星, 圣湘生物, 圣维荣泉, 张江科投
  > On 2026-03-12, according to Xiniu Data, Phil Rivers completed Series A+ financing, raising RMB 200 million. Investors were Shengxiang Biotechnology, Shengweirongquan, Zhangjiangketou, Zhongkechuangxing. (translated source brief)
- 2024-12-12 · Undisclosed · Strategic · 拓海鸿方
- 2022-06-15 · RMB 100M (≈ $14.3M) · Series A · 博行资本, 泰雅资本, 海金格医药, 诺禾致源

## Valuation

Listed 3 records.

- 2026-03-12 · amount unavailable · Series A+ · 中科创星, 圣湘生物, 圣维荣泉, 张江科投
  > On 2026-03-12, according to Xiniu Data, Phil Rivers completed Series A+ financing, raising RMB 200 million. Investors were Shengxiang Biotechnology, Shengweirongquan, Zhangjiangketou, Zhongkechuangxing. (translated source brief)
- 2024-12-12 · amount unavailable · Strategic · 拓海鸿方
- 2022-06-15 · amount unavailable · Series A · 博行资本, 泰雅资本, 海金格医药, 诺禾致源

## Revenue

No revenue records are listed yet.


## Team

No published team profiles are linked yet.

## Products

- [Zheyuan Technology](/products/zheyuankeji)

## Investors

- [中科创星](/institutions/zhongkechuangxing)
- [博行资本](/institutions/boxing-capital)
- [圣湘生物](/institutions/shengxiang-biotechnology)
- [圣维荣泉](/institutions/shengweirongquan)
- [张江科投](/institutions/zhangjiangketou)
- [拓海鸿方](/institutions/tuohaihongfang)
- [泰雅资本](/institutions/taiya-capital)
- [海金格医药](/institutions/haijinge-pharmaceutical)
- [诺禾致源](/institutions/nuohezhiyuan)

## Sources

- No source links are available for this profile.